Alberta Children's Hospital performs first liver cell transplant in Calgary, Canada

Published on November 29, 2012 at 11:49 PM · No Comments

A three-month-old Winnipeg girl has become the first patient in Canada to receive an experimental and potentially life-saving form of therapy to improve the function of her liver.

Physicians at Alberta Children's Hospital, led by medical geneticist Dr. Aneal Khan, successfully completed a series of liver cell transplants earlier this month on patient Nazdana Ali.

Nazdana was born last August with a Urea Cycle Disorder (UCD), a genetic disease that causes ammonia to build up in the body that, if untreated, would lead to brain damage and death. Ammonia is naturally produced as the body uses protein but, for those with UCDs, the process of converting ammonia to urea (a harmless substance which gives urine its yellow colour) does not work properly.

The condition is incurable and very rare: Alberta Children's Hospital treats about two children with a UCD per year. In Canada, about 50 babies are born annually with the condition.

Each time ammonia builds up, there is a risk of neurological damage but transplanted liver cells are expected to help Nazdana's liver to keep the ammonia down to safe levels.

"We have been monitoring Nazdana closely and are happy to report that she has tolerated the liver cell transplant well, she is stable and can return home to Winnipeg," says Dr. Khan, who is also an assistant professor of medical genetics and pediatrics at the University of Calgary, and a member of the U of C-AHS Alberta Children's Hospital Research Institute for Child and Maternal Health. "This could represent a big leap forward in managing these cases. It's a promising new bridge therapy that could improve the odds of Nazdana surviving until she is able to undergo a liver transplant."

The long-term stabilization of ammonia levels resulting from liver cell infusion buys children time until a matching liver can be found and transplanted.

To date the procedure has been performed in Germany, including an operation on a Canadian baby, and in a handful of centres in the U.S.

Without conventional treatment, most newborns with a UCD die within the first two weeks of life. Special medications and a protein-restricted diet improve survival rates but the brain remains exposed to high ammonia levels and even children who survive have a high risk of brain damage. The only long-term treatment is a liver transplant but a transplant in a small child has less chance of success and there is limited availability of organs.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment